English

Please Select Search Type

Please Enter Keywords

Please Select Search Type

Please Enter Keywords

English

Current Location:

Home

Reports

Global Human Vaccine Market Size, Competition Landscape and Supply Chain Research Report 2026

Published : 2026-01-25

Pages : 155

Tables and Figures : 170

Report ID : WENKH001340

Report Format :

Delivery : 48-72h

Select Type ：

Full Report

Competitive Landscape

Select Version ：

Single Users License：$ 3700

Buy Now

Request Sample

Custom Reports

Important Clause:

Recently, our company has discovered that some websites have plagiarized, quoted and modified our original report catalog without authorization, and sold reports under our brand, which has seriously infringed our interests. Therefore, our company recommends that you contact the relevant phone number, email address or leave a message to purchase the report to prevent being deceived.

*All report contents displayed on this website are original to WENKH, and our company has the sole copyright. Any modification, reprinting or quoting in any form is prohibited without our prior written permission. Otherwise, our company reserves the right to pursue legal responsibility.

Research Scope

Table of Contents

Tables and Figures

Full Report

Research Summary

Human vaccines are biological preparations designed to prevent, control, or eliminate infectious diseases in humans. Their principle is to use weakened, inactivated, or genetically engineered forms of pathogens or their components to stimulate the human immune system to generate specific immune responses, enabling rapid recognition and defense against infection upon real exposure. Based on preparation methods and composition, vaccines can be classified into live attenuated vaccines, inactivated vaccines, subunit vaccines, peptide vaccines, virus-like particle vaccines, nucleic acid vaccines (DNA vaccines, mRNA vaccines), and viral vector vaccines. Live attenuated vaccines, such as measles and BCG, can induce long-lasting immunity but must be used cautiously in immunocompromised individuals. Inactivated vaccines, such as hepatitis A vaccines, are safer and easier to store. Subunit and recombinant vaccines, such as hepatitis B vaccines, are widely used for routine immunization due to fewer side effects. Nucleic acid vaccines and viral vector vaccines represent next-generation platforms and were applied on a large scale during the COVID-19 pandemic. Beyond protecting individuals, vaccines reduce morbidity and mortality at the population level and contribute to herd immunity, making them indispensable tools for global public health and infectious disease prevention.

According to WENKH research statistics, the global Human Vaccine market size will reach 40,731 Million USD in 2026 and is projected to reach 56,817 Million USD by 2033, with a CAGR of 4.87% (2026-2033). Among them, the Asia-Pacific Human Vaccine market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.

The global Human Vaccine market is highly competitive, with key market players including CNBG, Changsheng Life, Zhifei, ChengDa Bio, Kangtai, SINOVAC BIOTECH, Hissen, Walvax Biotechnology, GSK, SANOFI, Rong An, NuoCheng Bio, Hualan Bio, Tiantan biological, Changchun Baike, Adimmune, Zhongyianke Biotech, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Indian Immunologicals, KANGH, ZhongKe Biopharm, Henan Grand Biopharma, Zhuoyi Biological, etc. This report categorizes the competitive landscape of the global Human Vaccine market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.

This report provides an in-depth analysis of the global Human Vaccine market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Human Vaccine industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Human Vaccine and their downstream application fields.

In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Human Vaccine in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Human Vaccine market. By considering local policies, this report evaluates the market prospects of Human Vaccine in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

CNBG

Changsheng Life

Zhifei

ChengDa Bio

Kangtai

SINOVAC BIOTECH

Hissen

Walvax Biotechnology

GSK

SANOFI

Rong An

NuoCheng Bio

Hualan Bio

Tiantan biological

Changchun Baike

Adimmune

Zhongyianke Biotech

Bharat Biotech

Bavarian Nordic

Sanofi-Pasteur

Indian Immunologicals

KANGH

ZhongKe Biopharm

Henan Grand Biopharma

Zhuoyi Biological

Product Segment

Varicella

Influenza

Polio

Hepatitis A

Rabies

BCG

Hepatitis B

Pertussis, Diphtheria, Tetanus

Pneumococcal

Rota Vaccine

Product Application

Adults

Children

Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Human Vaccine Industry Chain Analysis

Chapter 3: Global Human Vaccine Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Human Vaccine Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Human Vaccine Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Human Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Human Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Human Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Human Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Human Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Human Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source

Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.

Table of Content

1 Human Vaccine Market Overview

1.1 Product Definition Introduction

1.2 Global Human Vaccine Market Size and Growth Forecast Analysis (2021-2033)

1.3 Human Vaccine Market Status and Development Prospects

1.3.1 Human Vaccine Market Status

1.3.2 Human Vaccine Industry Development Prospects

1.4 Human Vaccine Market Overview by Product Segment

1.4.1 Global Human Vaccine Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033

1.4.2 Varicella

1.4.3 Influenza

1.4.4 Polio

1.4.5 Hepatitis A

1.4.6 Rabies

1.4.7 BCG

1.4.8 Hepatitis B

1.4.9 Pertussis, Diphtheria, Tetanus

1.4.10 Pneumococcal

1.4.11 Rota Vaccine

1.5 Human Vaccine Market Overview by Product Application

1.5.1 Global Human Vaccine Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033

1.5.2 Adults

1.5.3 Children

2 Human Vaccine Industry Supply Chain Analysis

2.1 Human Vaccine Supply Chain

2.2 Human Vaccine Industry Upstream Supply Analysis

2.2.1 Upstream Raw Materials Supply Status

2.2.2 Key Raw Material Suppliers

2.3 Human Vaccine Midstream Manufacturers

2.4 Human Vaccine Downstream Customers

2.5 Human Vaccine Sales Channel Analysis

3 Human Vaccine Market Environment Analysis

3.1 Human Vaccine Industry Policy Analysis

3.2 Human Vaccine Emerging Technology Trends in the Industry

3.3 Human Vaccine Restraining Factors Analysis

3.4 Human Vaccine Market Porter's Five Forces Analysis

3.4.1 Competitive Rivalry

3.4.2 Threat of New Entrants

3.4.3 Bargaining Power of Suppliers

3.4.4 Bargaining Power of Buyers

3.4.5 Threat of Substitute Products or Services

4 Global Human Vaccine Manufacturer Competition Landscape

4.1 Global Human Vaccine Market Sales Volume, Revenue by Key Manufacturers (2021-2026)

4.1.1 Global Human Vaccine Market Sales Volume by Key Manufacturers (2021-2026)

4.1.2 Global Human Vaccine Market Revenue by Key Manufacturers (2021-2026)

4.2 Global Human Vaccine Market Position by Key Manufacturers

4.3 China Human Vaccine Market Position by Key Manufacturers

4.4 Global Key Manufacturers Headquarter and Key Area Served

4.5 Global Human Vaccine Market Expansion and M&A Dynamic

5 In-depth Analysis of Key Players

5.1 CNBG

5.1.1 CNBG Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.1.2 CNBG Human Vaccine Product Features

5.1.3 CNBG Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.1.4 CNBG Human Vaccine Revenue by Product Segment

5.1.5 CNBG Human Vaccine Revenue by Region

5.2 Changsheng Life

5.2.1 Changsheng Life Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.2.2 Changsheng Life Human Vaccine Product Features

5.2.3 Changsheng Life Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.2.4 Changsheng Life Human Vaccine Revenue by Product Segment

5.2.5 Changsheng Life Human Vaccine Revenue by Region

5.3 Zhifei

5.3.1 Zhifei Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.3.2 Zhifei Human Vaccine Product Features

5.3.3 Zhifei Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.3.4 Zhifei Human Vaccine Revenue by Product Segment

5.3.5 Zhifei Human Vaccine Revenue by Region

5.4 ChengDa Bio

5.4.1 ChengDa Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.4.2 ChengDa Bio Human Vaccine Product Features

5.4.3 ChengDa Bio Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.4.4 ChengDa Bio Human Vaccine Revenue by Product Segment

5.4.5 ChengDa Bio Human Vaccine Revenue by Region

5.5 Kangtai

5.5.1 Kangtai Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.5.2 Kangtai Human Vaccine Product Features

5.5.3 Kangtai Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.5.4 Kangtai Human Vaccine Revenue by Product Segment

5.5.5 Kangtai Human Vaccine Revenue by Region

5.6 SINOVAC BIOTECH

5.6.1 SINOVAC BIOTECH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.6.2 SINOVAC BIOTECH Human Vaccine Product Features

5.6.3 SINOVAC BIOTECH Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.6.4 SINOVAC BIOTECH Human Vaccine Revenue by Product Segment

5.6.5 SINOVAC BIOTECH Human Vaccine Revenue by Region

5.7 Hissen

5.7.1 Hissen Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.7.2 Hissen Human Vaccine Product Features

5.7.3 Hissen Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.7.4 Hissen Human Vaccine Revenue by Product Segment

5.7.5 Hissen Human Vaccine Revenue by Region

5.8 Walvax Biotechnology

5.8.1 Walvax Biotechnology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.8.2 Walvax Biotechnology Human Vaccine Product Features

5.8.3 Walvax Biotechnology Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.8.4 Walvax Biotechnology Human Vaccine Revenue by Product Segment

5.8.5 Walvax Biotechnology Human Vaccine Revenue by Region

5.9 GSK

5.9.1 GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.9.2 GSK Human Vaccine Product Features

5.9.3 GSK Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.9.4 GSK Human Vaccine Revenue by Product Segment

5.9.5 GSK Human Vaccine Revenue by Region

5.10 SANOFI

5.10.1 SANOFI Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.10.2 SANOFI Human Vaccine Product Features

5.10.3 SANOFI Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.10.4 SANOFI Human Vaccine Revenue by Product Segment

5.10.5 SANOFI Human Vaccine Revenue by Region

5.11 Rong An

5.11.1 Rong An Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.11.2 Rong An Human Vaccine Product Features

5.11.3 Rong An Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.11.4 Rong An Human Vaccine Revenue by Product Segment

5.11.5 Rong An Human Vaccine Revenue by Region

5.12 NuoCheng Bio

5.12.1 NuoCheng Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.12.2 NuoCheng Bio Human Vaccine Product Features

5.12.3 NuoCheng Bio Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.12.4 NuoCheng Bio Human Vaccine Revenue by Product Segment

5.12.5 NuoCheng Bio Human Vaccine Revenue by Region

5.13 Hualan Bio

5.13.1 Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.13.2 Hualan Bio Human Vaccine Product Features

5.13.3 Hualan Bio Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.13.4 Hualan Bio Human Vaccine Revenue by Product Segment

5.13.5 Hualan Bio Human Vaccine Revenue by Region

5.14 Tiantan biological

5.14.1 Tiantan biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.14.2 Tiantan biological Human Vaccine Product Features

5.14.3 Tiantan biological Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.14.4 Tiantan biological Human Vaccine Revenue by Product Segment

5.14.5 Tiantan biological Human Vaccine Revenue by Region

5.15 Changchun Baike

5.15.1 Changchun Baike Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.15.2 Changchun Baike Human Vaccine Product Features

5.15.3 Changchun Baike Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.15.4 Changchun Baike Human Vaccine Revenue by Product Segment

5.15.5 Changchun Baike Human Vaccine Revenue by Region

5.16 Adimmune

5.16.1 Adimmune Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.16.2 Adimmune Human Vaccine Product Features

5.16.3 Adimmune Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.16.4 Adimmune Human Vaccine Revenue by Product Segment

5.16.5 Adimmune Human Vaccine Revenue by Region

5.17 Zhongyianke Biotech

5.17.1 Zhongyianke Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.17.2 Zhongyianke Biotech Human Vaccine Product Features

5.17.3 Zhongyianke Biotech Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.17.4 Zhongyianke Biotech Human Vaccine Revenue by Product Segment

5.17.5 Zhongyianke Biotech Human Vaccine Revenue by Region

5.18 Bharat Biotech

5.18.1 Bharat Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.18.2 Bharat Biotech Human Vaccine Product Features

5.18.3 Bharat Biotech Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.18.4 Bharat Biotech Human Vaccine Revenue by Product Segment

5.18.5 Bharat Biotech Human Vaccine Revenue by Region

5.19 Bavarian Nordic

5.19.1 Bavarian Nordic Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.19.2 Bavarian Nordic Human Vaccine Product Features

5.19.3 Bavarian Nordic Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.19.4 Bavarian Nordic Human Vaccine Revenue by Product Segment

5.19.5 Bavarian Nordic Human Vaccine Revenue by Region

5.20 Sanofi-Pasteur

5.20.1 Sanofi-Pasteur Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.20.2 Sanofi-Pasteur Human Vaccine Product Features

5.20.3 Sanofi-Pasteur Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.20.4 Sanofi-Pasteur Human Vaccine Revenue by Product Segment

5.20.5 Sanofi-Pasteur Human Vaccine Revenue by Region

5.21 Indian Immunologicals

5.21.1 Indian Immunologicals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.21.2 Indian Immunologicals Human Vaccine Product Features

5.21.3 Indian Immunologicals Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.21.4 Indian Immunologicals Human Vaccine Revenue by Product Segment

5.21.5 Indian Immunologicals Human Vaccine Revenue by Region

5.22 KANGH

5.22.1 KANGH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.22.2 KANGH Human Vaccine Product Features

5.22.3 KANGH Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.22.4 KANGH Human Vaccine Revenue by Product Segment

5.22.5 KANGH Human Vaccine Revenue by Region

5.23 ZhongKe Biopharm

5.23.1 ZhongKe Biopharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.23.2 ZhongKe Biopharm Human Vaccine Product Features

5.23.3 ZhongKe Biopharm Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.23.4 ZhongKe Biopharm Human Vaccine Revenue by Product Segment

5.23.5 ZhongKe Biopharm Human Vaccine Revenue by Region

5.24 Henan Grand Biopharma

5.24.1 Henan Grand Biopharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.24.2 Henan Grand Biopharma Human Vaccine Product Features

5.24.3 Henan Grand Biopharma Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.24.4 Henan Grand Biopharma Human Vaccine Revenue by Product Segment

5.24.5 Henan Grand Biopharma Human Vaccine Revenue by Region

5.25 Zhuoyi Biological

5.25.1 Zhuoyi Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

5.25.2 Zhuoyi Biological Human Vaccine Product Features

5.25.3 Zhuoyi Biological Human Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2026)

5.25.4 Zhuoyi Biological Human Vaccine Revenue by Product Segment

5.25.5 Zhuoyi Biological Human Vaccine Revenue by Region

6 Global Human Vaccine Market Analysis by Regions, by Product Segment and Application

6.1 Global Human Vaccine Market Size and Growth Forecast by Region: 2021 VS 2026 VS 2033

6.1.1 Global Human Vaccine Market Revenue by Region (2021-2026)

6.1.2 Global Human Vaccine Market Revenue Forecast by Region (2027-2033)

6.2 Global Human Vaccine Market Sales Volume Analysis

6.2.1 Global Human Vaccine Market Sales Volume by Region (2021-2026)

6.2.2 Global Human Vaccine Market Sales Volume Forecast by Region (2027-2033)

6.3 Global Human Vaccine Market by Product Segment (2021-2033)

6.3.1 Global Human Vaccine Market Revenue and Forecast by Product Segment

6.3.2 Global Human Vaccine Market Sales Volume and Forecast by Product Segment

6.4 Global Human Vaccine Market by Product Application (2021-2033)

6.4.1 Global Human Vaccine Market Revenue and Forecast by Product Application

6.4.2 Global Human Vaccine Market Sales Volume and Forecast by Product Application

7 North America Human Vaccine Market Analysis

7.1 North America Human Vaccine Market Prospects

7.1.1 North America Human Vaccine Market Revenue and Growth Forecast by Countries (2021-2033)

7.1.2 North America Human Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

7.1.3 U.S.

7.1.4 Canada

7.2 North America Human Vaccine Market by Product Segment (2021-2033)

7.2.1 North America Human Vaccine Market Revenue and Forecast Analysis by Product Segment

7.2.2 North America Human Vaccine Market Sales Volume and Forecast Analysis by Product Segment

7.3 North America Human Vaccine Market by Product Application (2021-2033)

7.3.1 North America Human Vaccine Market Revenue and Forecast Analysis by Product Application

7.3.2 North America Human Vaccine Market Sales Volume and Forecast Analysis by Product Application

8 Europe Human Vaccine Market Analysis

8.1 Europe Human Vaccine Market Prospects

8.1.1 Europe Human Vaccine Market Revenue and Growth Forecast by Countries (2021-2033)

8.1.2 Europe Human Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

8.1.3 Germany

8.1.4 France

8.1.5 United Kingdom

8.1.6 Italy

8.1.7 Spain

8.1.8 Benelux

8.2 Europe Human Vaccine Market by Product Segment (2021-2033)

8.2.1 Europe Human Vaccine Market Revenue and Forecast Analysis by Product Segment

8.2.2 Europe Human Vaccine Market Sales Volume and Forecast Analysis by Product Segment

8.3 Europe Human Vaccine Market by Product Application (2021-2033)

8.3.1 Europe Human Vaccine Market Revenue and Forecast Analysis by Product Application

8.3.2 Europe Human Vaccine Market Sales Volume and Forecast Analysis by Product Application

9 China Human Vaccine Market Analysis

9.1 China Human Vaccine Market Prospects

9.1.1 China Human Vaccine Revenue and Growth Forecast (2021-2033)

9.1.2 China Human Vaccine Market Sales Volume and Growth Forecast (2021-2033)

9.2 China Human Vaccine Market by Product Segment (2021-2033)

9.2.1 China Human Vaccine Market Revenue and Forecast Analysis by Product Segment

9.2.2 China Human Vaccine Market Sales Volume and Forecast Analysis by Product Segment

9.3 China Human Vaccine Market by Product Application (2021-2033)

9.3.1 China Human Vaccine Market Revenue and Forecast Analysis by Product Application

9.3.2 China Human Vaccine Market Sales Volume and Forecast Analysis by Product Application

10 Asia Pacific (excl. China) Human Vaccine Market Analysis

10.1 Asia Pacific (excl. China) Human Vaccine Market Prospects

10.1.1 Asia Pacific (excl. China) Human Vaccine Revenue and Growth Forecast by Countries (2021-2033)

10.1.2 Asia Pacific (excl. China) Human Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

10.1.3 Japan

10.1.4 South Korea

10.1.5 India

10.1.6 Southeast Asia

10.1.7 Australia

10.2 Asia Pacific (excl. China) Human Vaccine Market by Product Segment (2021-2033)

10.2.1 Asia Pacific (excl. China) Human Vaccine Market Revenue and Forecast Analysis by Product Segment

10.2.2 Asia Pacific (excl. China) Human Vaccine Market Sales Volume and Forecast Analysis by Product Segment

10.3 Asia Pacific (excl. China) Human Vaccine Market by Product Application (2021-2033)

10.3.1 Asia Pacific (excl. China) Human Vaccine Market Revenue and Forecast Analysis by Product Application

10.3.2 Asia Pacific (excl. China) Human Vaccine Market Sales Volume and Forecast Analysis by Product Application

11 Latin America Human Vaccine Market Analysis

11.1 Latin America Human Vaccine Market Prospects

11.1.1 Latin America Human Vaccine Revenue and Growth Forecast by Countries (2021-2033)

11.1.2 Latin America Human Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

11.1.3 Mexico

11.1.4 Brazil

11.2 Latin America Human Vaccine Market by Product Segment (2021-2033)

11.2.1 Latin America Human Vaccine Market Revenue and Forecast Analysis by Product Segment

11.2.2 Latin America Human Vaccine Market Sales Volume and Forecast Analysis by Product Segment

11.3 Latin America Human Vaccine Market by Product Application (2021-2033)

11.3.1 Latin America Human Vaccine Market Revenue and Forecast Analysis by Product Application

11.3.2 Latin America Human Vaccine Market Sales Volume and Forecast Analysis by Product Application

12 Middle East and Africa Human Vaccine Market Analysis

12.1 Middle East and Africa Human Vaccine Market Prospects

12.1.1 Middle East and Africa Human Vaccine Revenue and Growth Forecast by Countries (2021-2033)

12.1.2 Middle East and Africa Human Vaccine Sales Volume and Growth Forecast by Countries (2021-2033)

12.1.3 Saudi Arabia

12.1.4 South Africa

12.2 Middle East and Africa Human Vaccine Market by Product Segment (2021-2033)

12.2.1 Middle East and Africa Human Vaccine Market Revenue and Forecast Analysis by Product Segment

12.2.2 Middle East and Africa Human Vaccine Market Sales Volume and Forecast Analysis by Product Segment

12.3 Middle East and Africa Human Vaccine Market by Product Application (2021-2033)

12.3.1 Middle East and Africa Human Vaccine Market Revenue and Forecast Analysis by Product Application

12.3.2 Middle East and Africa Human Vaccine Market Sales Volume and Forecast Analysis by Product Application

13 Research Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.2 Research Landscape

14.3 Research Benchmark and Hypothesis

14.4 Data Source

14.4.1 Primary Sources

14.4.2 Secondary Sources

14.5 Data Cross Validation

14.6 Disclaimer

Table 1：Global Human Vaccine Product Segment Market Size and Growth Forecast Analysis (2021 VS 2026 VS 2033) & (Million USD)

Table 2：Global Human Vaccine Market Size and Growth Forecast Analysis by Application (2021 VS 2026 VS 2033) & (Million USD)

Table 3：Key Raw Materials and Market Concentration

Table 4：Human Vaccine Raw Material Suppliers and Contact Information

Table 5：Human Vaccine Downstream Customers List

Table 6：Human Vaccine Distributors/Dealers List

Table 7：Global Human Vaccine Capacity by Countries (2021-2026) & (K Doses)

Table 8：Global Human Vaccine Production by Countries (2021-2026) & (K Doses)

Table 9：Global Human Vaccine Market Sales Volume by Key Manufacturers (2021-2026) & (K Doses)

Table 10：Global Human Vaccine Market Revenue by Key Manufacturers (2021-2026) & (Million USD)

Table 11：Global Human Vaccine Market Position by Key Manufacturers

Table 12：China Human Vaccine Market Position by Key Manufacturers

Table 13：Global Key Manufacturers Headquarter and Key Area Served

Table 14：Global Human Vaccine Market Expansion and M&A Dynamic

Table 15：CNBG Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 16：CNBG Human Vaccine Product Features

Table 17：CNBG Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 18：CNBG Human Vaccine Revenue by Product Segment

Table 19：CNBG Human Vaccine Revenue by Region

Table 20：Changsheng Life Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 21：Changsheng Life Human Vaccine Product Features

Table 22：Changsheng Life Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 23：Changsheng Life Human Vaccine Revenue by Product Segment

Table 24：Changsheng Life Human Vaccine Revenue by Region

Table 25：Zhifei Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 26：Zhifei Human Vaccine Product Features

Table 27：Zhifei Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 28：Zhifei Human Vaccine Revenue by Product Segment

Table 29：Zhifei Human Vaccine Revenue by Region

Table 30：ChengDa Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 31：ChengDa Bio Human Vaccine Product Features

Table 32：ChengDa Bio Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 33：ChengDa Bio Human Vaccine Revenue by Product Segment

Table 34：ChengDa Bio Human Vaccine Revenue by Region

Table 35：Kangtai Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 36：Kangtai Human Vaccine Product Features

Table 37：Kangtai Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 38：Kangtai Human Vaccine Revenue by Product Segment

Table 39：Kangtai Human Vaccine Revenue by Region

Table 40：SINOVAC BIOTECH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 41：SINOVAC BIOTECH Human Vaccine Product Features

Table 42：SINOVAC BIOTECH Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 43：SINOVAC BIOTECH Human Vaccine Revenue by Product Segment

Table 44：SINOVAC BIOTECH Human Vaccine Revenue by Region

Table 45：Hissen Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 46：Hissen Human Vaccine Product Features

Table 47：Hissen Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 48：Hissen Human Vaccine Revenue by Product Segment

Table 49：Hissen Human Vaccine Revenue by Region

Table 50：Walvax Biotechnology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 51：Walvax Biotechnology Human Vaccine Product Features

Table 52：Walvax Biotechnology Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 53：Walvax Biotechnology Human Vaccine Revenue by Product Segment

Table 54：Walvax Biotechnology Human Vaccine Revenue by Region

Table 55：GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 56：GSK Human Vaccine Product Features

Table 57：GSK Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 58：GSK Human Vaccine Revenue by Product Segment

Table 59：GSK Human Vaccine Revenue by Region

Table 60：SANOFI Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 61：SANOFI Human Vaccine Product Features

Table 62：SANOFI Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 63：SANOFI Human Vaccine Revenue by Product Segment

Table 64：SANOFI Human Vaccine Revenue by Region

Table 65：Rong An Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 66：Rong An Human Vaccine Product Features

Table 67：Rong An Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 68：Rong An Human Vaccine Revenue by Product Segment

Table 69：Rong An Human Vaccine Revenue by Region

Table 70：NuoCheng Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 71：NuoCheng Bio Human Vaccine Product Features

Table 72：NuoCheng Bio Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 73：NuoCheng Bio Human Vaccine Revenue by Product Segment

Table 74：NuoCheng Bio Human Vaccine Revenue by Region

Table 75：Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 76：Hualan Bio Human Vaccine Product Features

Table 77：Hualan Bio Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 78：Hualan Bio Human Vaccine Revenue by Product Segment

Table 79：Hualan Bio Human Vaccine Revenue by Region

Table 80：Tiantan biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 81：Tiantan biological Human Vaccine Product Features

Table 82：Tiantan biological Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 83：Tiantan biological Human Vaccine Revenue by Product Segment

Table 84：Tiantan biological Human Vaccine Revenue by Region

Table 85：Changchun Baike Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 86：Changchun Baike Human Vaccine Product Features

Table 87：Changchun Baike Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 88：Changchun Baike Human Vaccine Revenue by Product Segment

Table 89：Changchun Baike Human Vaccine Revenue by Region

Table 90：Adimmune Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 91：Adimmune Human Vaccine Product Features

Table 92：Adimmune Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 93：Adimmune Human Vaccine Revenue by Product Segment

Table 94：Adimmune Human Vaccine Revenue by Region

Table 95：Zhongyianke Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 96：Zhongyianke Biotech Human Vaccine Product Features

Table 97：Zhongyianke Biotech Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 98：Zhongyianke Biotech Human Vaccine Revenue by Product Segment

Table 99：Zhongyianke Biotech Human Vaccine Revenue by Region

Table 100：Bharat Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 101：Bharat Biotech Human Vaccine Product Features

Table 102：Bharat Biotech Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 103：Bharat Biotech Human Vaccine Revenue by Product Segment

Table 104：Bharat Biotech Human Vaccine Revenue by Region

Table 105：Bavarian Nordic Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 106：Bavarian Nordic Human Vaccine Product Features

Table 107：Bavarian Nordic Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 108：Bavarian Nordic Human Vaccine Revenue by Product Segment

Table 109：Bavarian Nordic Human Vaccine Revenue by Region

Table 110：Sanofi-Pasteur Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 111：Sanofi-Pasteur Human Vaccine Product Features

Table 112：Sanofi-Pasteur Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 113：Sanofi-Pasteur Human Vaccine Revenue by Product Segment

Table 114：Sanofi-Pasteur Human Vaccine Revenue by Region

Table 115：Indian Immunologicals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 116：Indian Immunologicals Human Vaccine Product Features

Table 117：Indian Immunologicals Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 118：Indian Immunologicals Human Vaccine Revenue by Product Segment

Table 119：Indian Immunologicals Human Vaccine Revenue by Region

Table 120：KANGH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 121：KANGH Human Vaccine Product Features

Table 122：KANGH Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 123：KANGH Human Vaccine Revenue by Product Segment

Table 124：KANGH Human Vaccine Revenue by Region

Table 125：ZhongKe Biopharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 126：ZhongKe Biopharm Human Vaccine Product Features

Table 127：ZhongKe Biopharm Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 128：ZhongKe Biopharm Human Vaccine Revenue by Product Segment

Table 129：ZhongKe Biopharm Human Vaccine Revenue by Region

Table 130：Henan Grand Biopharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 131：Henan Grand Biopharma Human Vaccine Product Features

Table 132：Henan Grand Biopharma Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 133：Henan Grand Biopharma Human Vaccine Revenue by Product Segment

Table 134：Henan Grand Biopharma Human Vaccine Revenue by Region

Table 135：Zhuoyi Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 136：Zhuoyi Biological Human Vaccine Product Features

Table 137：Zhuoyi Biological Human Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2026)

Table 138：Zhuoyi Biological Human Vaccine Revenue by Product Segment

Table 139：Zhuoyi Biological Human Vaccine Revenue by Region

Table 140：Global Human Vaccine Market Size and Growth Forecast by Region (2021 VS 2026 VS 2033) & (Million USD)

Table 141：Global Human Vaccine Market Revenue by Region (2021-2026) & (Million USD)

Table 142：Global Human Vaccine Market Share by Region (2021-2026)

Table 143：Global Human Vaccine Market Revenue Forecast by Region (2027-2033) & (Million USD)

Table 144：Global Human Vaccine Market Share Forecast by Region (2027-2033)

Table 145：Global Human Vaccine Market Sales by Region (2021-2026) & (K Doses)

Table 146：Global Human Vaccine Sales Volume Market Share by Region (2021-2026)

Table 147：Global Human Vaccine Market Sales Volume Forecast by Region (2027-2033) & (K Doses)

Table 148：Global Human Vaccine Sales Volume Market Share Forecast by Region (2027-2033)

Table 149：Global Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 150：Global Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 151：Global Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 152：Global Human Vaccine Market Sales Volume Forecast by Product Segment (2027-2033) & (K Doses)

Table 153：Global Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 154：Global Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 155：Global Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 156：Global Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 157：North America Human Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 158：North AmericaHuman Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 159：North America Human Vaccine Market Sales Volume by Countries (2021-2026) & K Doses)

Table 160：North America Human Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 161：North America Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 162：North America Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 163：North America Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 164：North America Human Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 165：North America Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 166：North America Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 167：North America Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 168：North America Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 169：Europe Human Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 170：Europe Human Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 171：Europe Human Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 172：Europe Human Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 173：Europe Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 174：Europe Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 175：Europe Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 176：Europe Human Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 177：Europe Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 178：Europe Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 179：Europe Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 180：Europe Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 181：China Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 182：China Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 183：China Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 184：China Human Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 185：China Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 186：China Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 187：China Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 188：China Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 189：Asia Pacific (excl. China) Human Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 190：Asia Pacific (excl. China) Human Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 191：Asia Pacific (excl. China) Human Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 192：Asia Pacific (excl. China) Human Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 193：Asia Pacific (excl. China) Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 194：Asia Pacific (excl. China) Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 195：Asia Pacific (excl. China) Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 196：Asia Pacific (excl. China) Human Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 197：Asia Pacific (excl. China) Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 198：Asia Pacific (excl. China) Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 199：Asia Pacific (excl. China) Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 200：Asia Pacific (excl. China) Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 201：Latin America Human Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 202：Latin America Human Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 203：Latin America Human Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 204：Latin America Human Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 205：Latin America Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 206：Latin America Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 207：Latin America Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 208：Latin America Human Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 209：Latin America Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 210：Latin America Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 211：Latin America Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 212：Latin America Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 213：Middle East and Africa Human Vaccine Market Revenue by Countries (2021-2026) & (Million USD)

Table 214：Middle East and Africa Human Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)

Table 215：Middle East and Africa Human Vaccine Market Sales Volume by Countries (2021-2026) & (K Doses)

Table 216：Middle East and Africa Human Vaccine Market Sales Volume Forecast by Countries (2027-2033) & (K Doses)

Table 217：Middle East and Africa Human Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)

Table 218：Middle East and Africa Human Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)

Table 219：Middle East and Africa Human Vaccine Market Sales Volume by Product Segment (2021-2026) & (K Doses)

Table 220：Middle East and Africa Human Vaccine Market Sales Volume Forecast by Segment (2027-2033) & (K Doses)

Table 221：Middle East and Africa Human Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)

Table 222：Middle East and Africa Human Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)

Table 223：Middle East and Africa Human Vaccine Market Sales Volume by Product Application (2021-2026) & (K Doses)

Table 224：Middle East and Africa Human Vaccine Market Sales Volume Forecast by Product Application (2027-2033) & (K Doses)

Table 225：Secondary Sources

Figure 1：Human Vaccine Product Scope

Figure 2：Global Human Vaccine Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)

Figure 3：Global Human Vaccine Sales Volume and Growth Forecast Analysis (2021-2033) & (K Doses)

Figure 4：Global Human Vaccine Product Segment Market Share (2026 & 2033)

Figure 5：Global Human Vaccine Product Application Market Share (2026 & 2033)

Figure 6：Varicella Product Scope

Figure 7：Influenza Product Scope

Figure 8：Polio Product Scope

Figure 9：Hepatitis A Product Scope

Figure 10：Rabies Product Scope

Figure 11：BCG Product Scope

Figure 12：Hepatitis B Product Scope

Figure 13：Pertussis, Diphtheria, Tetanus Product Scope

Figure 14：Pneumococcal Product Scope

Figure 15：Rota Vaccine Product Scope

Figure 16：Adults Product Scope

Figure 17：Children Product Scope

Figure 18：Human Vaccine Industrial Chain Framework

Figure 19：Global Human Vaccine Capacity, Production and Utilization (2021-2033) & (K Doses)

Figure 20：Global Human Vaccine Market by Geographic Segmentation in 2026

Figure 21：Global Human Vaccine Market Share by Region (2021 VS 2026)

Figure 22：Global Human Vaccine Sales Volume Market Share by Region (2021 VS 2026)

Figure 23：North America Human Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 24：North America Human Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 25：North America Human Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 26：U.S. Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 27：U.S. Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 28：Canada Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 29：Canada Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 30：Europe Human Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 31：Europe Human Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 32：Europe Human Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 33：Germany Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 34：Germany Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 35：France Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 36：France Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 37：United Kingdom Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 38：United Kingdom Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 39：Italy Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 40：Italy Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 41：Spain Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 42：Spain Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 43：Benelux Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 44：Benelux Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 45：China Human Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 46：China Human Vaccine Market Sales Volume and Growth Forecast (K Doses)

Figure 47：Asia Pacific (excl. China) Human Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 48：Asia Pacific (excl. China) Human Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 49：Asia Pacific (excl. China) Human Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 50：Japan Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 51：Japan Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 52：South Korea Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 53：South Korea Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 54：India Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 55：India Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 56：Southeast Asia Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 57：Southeast Asia Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 58：Australia Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 59：Australia Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 60：Latin America Human Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 61：Latin America Human Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 62：Latin America Human Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 63：Mexico Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 64：Mexico Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 65：Brazil Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 66：Brazil Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 67：Middle East and Africa Human Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)

Figure 68：Middle East and Africa Human Vaccine Revenue Market Share by Countries (2026 VS 2033)

Figure 69：Middle East and Africa Human Vaccine Sales Volume Market Share by Countries (2026 VS 2033)

Figure 70：Saudi Arabia Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 71：Saudi Arabia Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 72：South Africa Human Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)

Figure 73：South Africa Human Vaccine Market Sales Volume and Forecast (2021-2033) & (K Doses)

Figure 74：Research Methodology

Figure 75：Primary Sources

Figure 76：Data Cross Validation

Related Reports

Global Healthcare Supply Chain Managements Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Healthcare Supply Chain Managements Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

Global Hemodialysis and Peritoneal Dialysis Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Hemodialysis and Peritoneal Dialysis Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

Global Pharmaceutical CDMO Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Pharmaceutical CDMO Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

Global Full-Service Clinical Research Organization (CRO) Market Competitors, Segment Types and Downstream Applications Research Report 2026

2026-01-25

Global Full-Service Clinical Research Organization (CRO) Market Size, Competition Landscape and Supply Chain Research Report 2026

2026-01-25

How to Order

Contact

Fill in your contact information, and the company will quickly match the specialist to get in touch with you

You can also directly call our customer service hotline or add customer service WeChat

Samples

One on one business specialist will send the complete version of the sample

If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples

Payment

Both parties sign a report purchase contract

Support Paypal, Visa, UnionPay and MasterCard Payment

Delivery

PDF report (sent online 2-3 working days after payment)

WORD version report (sent online 2-3 working days after payment)

Paper version report (sent via EMS or DHL within 3-5 working days after payment)

After-Sales

Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied

No Relevant Report Found? Please Contact Us

Custom Reports

WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.

About WENKH

+86-191 0717 4767 (Int'l)

market@wenkh.com

Ocean Tower, No.145, Hong Kong Road, Wuhan City, Hube Province, China

Revenue (US$ Million)	2020	2021	2022	2023	2024
CNBG	XX	XX	XX	XX	XX
Changsheng Life	XX	XX	XX	XX	XX
Zhifei	XX	XX	XX	XX	XX
ChengDa Bio	XX	XX	XX	XX	XX
Kangtai	XX	XX	XX	XX	XX
SINOVAC BIOTECH	XX	XX	XX	XX	XX
Hissen	XX	XX	XX	XX	XX
Walvax Biotechnology	XX	XX	XX	XX	XX
GSK	XX	XX	XX	XX	XX
SANOFI	XX	XX	XX	XX	XX
Rong An	XX	XX	XX	XX	XX
NuoCheng Bio	XX	XX	XX	XX	XX
Hualan Bio	XX	XX	XX	XX	XX
Tiantan biological	XX	XX	XX	XX	XX
Changchun Baike	XX	XX	XX	XX	XX
Adimmune	XX	XX	XX	XX	XX
Zhongyianke Biotech	XX	XX	XX	XX	XX
Bharat Biotech	XX	XX	XX	XX	XX
Bavarian Nordic	XX	XX	XX	XX	XX
Sanofi-Pasteur	XX	XX	XX	XX	XX
Indian Immunologicals	XX	XX	XX	XX	XX
KANGH	XX	XX	XX	XX	XX
ZhongKe Biopharm	XX	XX	XX	XX	XX
Henan Grand Biopharma	XX	XX	XX	XX	XX
Zhuoyi Biological	XX	XX	XX	XX	XX
Other Companies	XX	XX	XX	XX	XX
Total	XX	XX	XX	XX	XX

Sales (K Doses)	2020	2021	2022	2023	2024
CNBG	XX	XX	XX	XX	XX
Changsheng Life	XX	XX	XX	XX	XX
Zhifei	XX	XX	XX	XX	XX
ChengDa Bio	XX	XX	XX	XX	XX
Kangtai	XX	XX	XX	XX	XX
SINOVAC BIOTECH	XX	XX	XX	XX	XX
Hissen	XX	XX	XX	XX	XX
Walvax Biotechnology	XX	XX	XX	XX	XX
GSK	XX	XX	XX	XX	XX
SANOFI	XX	XX	XX	XX	XX
Rong An	XX	XX	XX	XX	XX
NuoCheng Bio	XX	XX	XX	XX	XX
Hualan Bio	XX	XX	XX	XX	XX
Tiantan biological	XX	XX	XX	XX	XX
Changchun Baike	XX	XX	XX	XX	XX
Adimmune	XX	XX	XX	XX	XX
Zhongyianke Biotech	XX	XX	XX	XX	XX
Bharat Biotech	XX	XX	XX	XX	XX
Bavarian Nordic	XX	XX	XX	XX	XX
Sanofi-Pasteur	XX	XX	XX	XX	XX
Indian Immunologicals	XX	XX	XX	XX	XX
KANGH	XX	XX	XX	XX	XX
ZhongKe Biopharm	XX	XX	XX	XX	XX
Henan Grand Biopharma	XX	XX	XX	XX	XX
Zhuoyi Biological	XX	XX	XX	XX	XX
Other Companies	XX	XX	XX	XX	XX
Total	XX	XX	XX	XX	XX